Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: NVCT) | Delayed: 20.70 +0.11 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.59 | 52 Week High | $ | |||
| Open | $20.63 | 52 Week Low | $ | |||
| Day High | $21.72 | P/E | N/A | |||
| Day Low | $19.94 | EPS | $ | |||
| Volume | 203,582 | |||||
